The effectiveness of Psychotherapy on reducing severity of symptoms Premenstrual Dysphoric Disorders

Document Type : Research Paper

Authors

1 Master of clinical Psychology, Islamic Azad University Birjand, Birjand, Iran

2 2. Full Professor of Clinical Psychology Azad University of Medical of sciences Tehran, Tehran,Iran.

3 Master of Psychology of Exceptional children, Islamic Azad University Birjand, Birjand, Iran

4 Master of Clinical Psychology, Islamic Azad University Torbbat-e Gam, Torbbat-e Gam, Iran

Abstract

Abstract
Introduction: Premenstrual dysphoric disorder is a series of repeated physical, psychological and behavioral symptoms that occur at the end of the menstrual cycle and resolves at the onset of menstruation and disrupts the function of the individual . Several therapies have been effective on it. Considering how the thoughts, emotions and emotions affect the growth or reduction of symptoms of this disorder; The   aim    of this research was to study  , the effectiveness of psychotherapy on reducing the symptoms of Premenstrual dysphoric disorders.
Method: This design of the study is pre­-test /post-test control group. The sample include 28 persons (14 group expermintal and 14 group control) of patient premenstrual dysphoric disorder the selected randomly and the were requested to answer Daily Record   of Severity of Problem chart (DRSP). Over 8 therapy sessions, each lasting 90 minutes cognitive-behaviour therapy  while the control group did not receive any intervention. Statistical software
SPSS (21) and Covariance analysis were applied to analyse  the data.
Results: The  result of data  analysis  showed psychotherapy with cognitive behavioral therapy approach caused the decrease severity of symptoms  premenstrual dysphoric disorder (symptoms of anxiety, depression and emotional symptoms) (acceptance and positive reappraisal) of experimental group of comparision to the witness group (p  >0/05  ).
Conclusion: The result of this study indicate the effectiveness of psychotherapy  in  reducing the severity of premenstrual dysphoric disorder.

Keywords

References

  1. Altemus,M. Neuroendocrine network and functional. Psychiatric Clinics of North America 2017; 40 (2): 189-200.
    2. Martines PE, Rubinow DR, Nieman, LK. 5 - reductase inhibition Prevents the luteal phase increase in plasma
    allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsy
    chopharmacology 2016; 41: 1093- 1102.
    3. Liao H, Duan G, Liu P, Liu Y, Pang Y, Liu H, Tang L, Tao J, Wen D, Li Sh, Liang L, Deng D. Attered fractional
    amplitude of low frequency fluctuation in premenstrual syndrome: A resting state fMRI stady. Journal of Affective
    Disorders 2017; 218: 41-48.
    4. Kaisera G, Jandaa C, Kleinstäuberb M , Weisea C. Clusters of premenstrual symptoms in women with PMDD:
    Appearance, stability and association with impairment. J chosomatic ResearchPsy 2018; 115: 38-43.
    5. Bezerrade Carvalhoa A, AzevedoCardosoa T , CamposMondina Th, Azevedoda Silvaa R, MattosSouzaa L D,
    SilvaMagalhãesb P V, Jansena K. Prevalence and factors associated with Premenstrual Dysphoric Disorder: A
    community sample of young adult women. Psychiatry Research 2018; 268: 42-44.
    6 . Janda C, Asbrock F, Herget M, Kues JN, Weise C. Change the perception of premenstrual dysphoric disorder - An
    online-experiment using the Stereotype Content Model. Journal of Psychosexual Health 2019; 1(1): 32-36.
    7. Bixo, M; Ekberg, k; Poromaa, I.S; Hirschbery, A.L; Jonasson, A.F; Andreen,L; Timby, E; Marianne, W; Ehrenborg,
    A & Backstrom, T. Treatment of premenstrual dysphoric with the GABA receptor modulating steroid antegonist
    sepranolone (UC1010)- A randomized controlled trial. Jornal of Psychoneuroendocrinology 2017; 80: 46- 55.
    8. Bosman R, Jung S, Miloserodoy K, Schoeyers R, Rot M. Daily symptom ratings for studing premenstrual dysphoric
    disorder. Journal of Affective Disorder 2016; 189: 46-639.
    9. Takeda T, Imoto y, Nagasawa H, Takeshita A, Shiina M. Fish Consumption and Premenstrual Syndrome and
    Dysphoric Disorder in Japanese Collegiate Athletes. Journal of Pediatric and Adolescent Coynecology 2016; 29(4);
    386-389.
    10. Chin L.N, Nambiar Sh. Managment of premenstrual Syndrome. Obstetrics Gynaecology & Reproductive Medicine
    2017; 27(1): 1-6.
    11. Orff H.J, Parry B.L. Premenstrual Dysphoric Disorder, Reference Module in Neuroscienc and Biobehavioral
    Psychology 2017; 4: 197-216.
  2. 12. Craner J.R, Sigmon S.T, Young M.A. Self- Focusea Attention and Symptoms Across Menstrual Cycle Phases in
    women with and without Premenstrual Disorders. Cognitive Therapy and Research 2016; 40(1): 118-127.
    13. Scalea TL, Pearlstein T. Premenstrual Dysphoric Disorder. Psychiatric Clinics of North America 2017 40 (2): 201-
    216.
    14. Shobeiri F,Ezati Araste F, Nazari M. The effect of calcium on physical symptoms of premenstrual syndrome. Iran J
    Obstet Gynecol Infertil 2016; 19(1): 7-15. (Persian).
    15. Kues JN, Janda C, Kleinstaeuber M, Weise C. Internet-based cognitive behavioural self-help for premenstrual
    syndrome: study protocol for a randomised controlled trial. Trials 2014; 15(1):472-81.
    16. Sepehri Rad M,Touzande Jani H. The study of the effectiveness of cognitive-behavioral cognitive behavioral
    training and traditional dietary therapy on depression and Physical Symptoms in Premenstrual Syndrome. Iran J Obstet
    Gynecol Infertil 2016; 18(177): 11-19. (Persian).
    17. Riggs S.E, Creed T.A. A Model to Transform Psychosis Milieu Treatment Using CBT Informed Interventions.
    Cognitive and Behavioral Practice 2017; 24(3): 353- 362.
    18. Camara R.A, Kohler C.A, Maes M, Nunes- Neto P.R, Brunoni A.R, Quevedo J, Fernandes B.S, Perugi G;
    Hyphantis T.N, Carvalho A.F. Affective tempraments and emotional traits are associate with a positive screening for
    premenstrual dysphoric disorder. Comprehenstryive Psychia 2016; 71: 33-38.
    19. Panahi F, Faramarzi,M. The effects Mindfulness-Based Cognitive Therapy on depression and Anxiety in women
    with premenstrual syndrome. Article ID 2016; 9816481, 7 pages.
    20. Maddineshat M, Keyvanloo S, Lashkardoost H, Arki M, Tabatabaeichehr M. Effectiveness of Group CognitiveBehavioral Therapy on Symptoms of Premenstrual Syndrome (PMS). Iranian journal of psychiatry 2016; 11(1), 30-36.
    21. Karami J, Zalipour S, Rahmani S, Zabet M. The Effectiveness of Web Therapy on the Symptoms of Premenstrual
    Syndrome. Journal of Urmia Nursing And Midwifery Faculty 2015; 13 (12): 1016-1021. (Persian).
    22. Mirghafourvand M, Malakouti J, Mohammad Alizadeh Charandabi S, Farshbaf Khalilic A, Ghanbari Homayi S.
    The efficacy of lemon balm (Melissa officinalis L.) alone and combined with lemon balm—Nepeta menthoides on
    premenstrual syndrome and quality of life among students: A randomized controlled trial. Journal of Herbal Medicine
    2016; 6: 142–148.
    23. Kimieaie Asadi F. K, Jadidian A. A, Aslani J. The Effect of Relaxation and Positive Self-Talk on Symptoms of
    Premenstrual Syndrome. Avicenna Journal of Neuro Psych Physiology 2016; 3(2): 1-6.
    24. Bluth K, Gaylord S, Ngugen, K, Bunevicius A, Girdler S. Mindfulness- based stress reduction as a promising
    intervention for amelioration of premenstrua dysphoric disorder symptoms. Mindfulness 2015; 6 (6): 1292-1302.
    25. Karimi Z, Alipour A, Mohtashami T. The effectiveness of combined Behavioral therapy and Calcium
    supplemention Plus Vitamin D on reducing the Premenstrual Syndrome. Arak Medical Univercity Journal 2015;
    18(96): 46-56. (Persian).
    26. Kleinstäuber M, Witthöft M, Hiller W. Cognitive-behavioral and pharmacological interventions for premenstrual
    syndrome or premenstrual dysphoric disorder: a meta-analysis. Journal of clinical psychology in medical settings
    2012; 19(3), 308-319.
    27. Vatankhaah H, Rahmani M, Hashemizadeh S. The effectiveness of cognitive-behavioral training on general health
    and reducing aggression in women with premenstrual syndrome. Interdisciplinary Journal of Contemporary Research In
    Business 2012; 4(9), 1098.
    28. Kathleen M, Lustyk B, Gerrish WG, Shaver Sh, Keys sh. Cognitive- behavioral therapy for premenstrual syndrome
    and premenstrual dysphonic disorder: a systematic review. Arch Women’s Mental Health 2009; 12:85-91.
    29. Hoffmans J, Richmond A, Landman F, Blom M. The effects of light therapy and cognitive behavioral therapy in
    premenstrual dysphoric disorder (PMDD). Journal of Affective Disorder 2008; 107 (1): 86-125.
    30. Davoudi I, Izadi Mazidi S, Mehrabizade M. The Effect of Cognitive-Behavioral Psychotherapy / Narrative on
    Premenstrual Syndrome in Female Students. . Iran J Obstet Gynecol Infertil 2012; 15(11): 7-15. (Persian).
    31. Eggert, L., Witthöft, M., Hiller, W., & Kleinstäuber, M. Emotion Regulation in Women with Premenstrual
    Syndrome (PMS): Explicit and Implicit Assessments. Cognitive Therapy and
    Research 2016; 40(6): 747-763.
    32. Eggert, L; Kleinstauber, M; Hiller, W & Witthoft, M. Emotional interference and attentional
    processing in premenstrual syndrom. Journal of Behavior therapy and Experimental Psychiatry 2017; 54: 77-87.
    33. Bruggink, A; Huisman, S; Vuijk, R; Kraaij, V & Granefski. Cognitive emotion regulation, anxiety
    and depression in edults with autism spectrum disorder. Research in Autism Spectrum Disorders 2016; 22: 34-44.
medical journal of mashhad university of medical sciences
Volume 63, Issue 1
May and June 2020
Pages 2196-2187

Files

Share

How to cite

Statistics